ESMO-ASIA 2024: Incyte Presentation
-4h 34m
Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025
-5h 11m
Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)
-5h 14m
Pasithea Therapeutics Corporation
Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)
-5h 19m
Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)
-5h 23m
Annual Report for Fiscal Year Ending 12-31, 2024 (Form 10-K)
-5h 30m
Neurogene Corporate Presentation March 2025
-5h 39m
Annual Report for Fiscal Year Ending December 31, 2024 (Form 20-F)
-5h 40m
Beyfortus approved in the EU for the prevention of RSV lower respiratory tract disease in infantsa
-5h 44m
-5h 44m